Pharmaids Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE117D01018
  • NSEID:
  • BSEID: 524572
INR
21.66
1.13 (5.5%)
BSENSE

Nov 20

BSE+NSE Vol: 18.77 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.66",
    "chg": 1.13,
    "chgp": "5.5%",
    "dir": 1,
    "prev_price": "20.53",
    "mcapval": "72.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE117D01018",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "18.77 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Pharmaids Pharmaceuticals Ltd to a New 52-Week Low",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2412-4268254",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PharmaidsPharma_priceRelatedfactors_4268254.png",
        "date": "2026-11-19 10:36:52",
        "description": ""
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 25.46 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-stock-hits-52-week-low-amidst-continued-downtrend-4267068",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PharmaidsPharma_priceRelatedfactors_4267068.png",
        "date": "2026-11-18 12:06:12",
        "description": "For the fourth consecutive session, Pharmaids Pharmaceuticals Ltd has declined, culminating in a fresh 52-week low of Rs 25.46 on 18 Nov 2026. This marks an 11.26% drop over the past four days, underscoring persistent selling pressure despite a broader market that has been relatively resilient."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ends Week Down 0.25% Amid Financial Struggles and Market Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/pharmaids-pharmaceuticals-ends-week-down-025-amid-financial-struggles-and-market-volatility-4261870",
        "imagepath": "",
        "date": "2026-11-14 15:02:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> Stock opens strong at Rs.30.00, gaining 5.01%</p>\n                    <p><strong>Nov 11:</strong> Price retreats to Rs.29.17 amid broader market gains</p>\n                    <p><strong>Nov 12:</strong> Negative financial trends reported; stock rebounds to Rs.29.84</p>\n                    <p><strong>Nov 13:</strong> Stock closes week lower at Rs.28.50, down 4.49% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.28.57</div>\n                    </div>\n                    <div clas..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Reports Negative Financial Trend Amidst Margin Pressures",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-reports-negative-financial-trend-amidst-margin-pressures-4259400",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/PharmaidsPharma_fintrenddot_4259400.png",
        "date": "2026-11-12 11:00:22",
        "description": "Pharmaids Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its recent quarterly financial performance. The company’s financial trend has shifted from flat to negative, reflecting significant contraction in revenue and profitability over the latest six-month period, raising concerns among investors and analysts alike."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4245423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PharmaidsPharma_mojoScore_4245423.png",
        "date": "2026-10-31 10:10:13",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4220026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PharmaidsPharma_mojoScore_4220026.png",
        "date": "2026-10-09 10:10:24",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 October 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4207116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PharmaidsPharma_mojoScore_4207116.png",
        "date": "2026-09-28 10:10:23",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4196245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PharmaidsPharma_mojoScore_4196245.png",
        "date": "2026-09-17 10:10:27",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4179559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PharmaidsPharma_mojoScore_4179559.png",
        "date": "2026-09-02 10:10:26",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 39,
    "sid": "799751",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Pharmaids Pharmaceuticals Ltd",
      "datetime": "20-Nov-2026",
      "details": "The Exchange has sought clarification from Pharmaids Pharmaceuticals Ltd on November 20 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2026",
      "details": "Newspaper publication of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "11-Nov-2026",
      "details": "outcome of the Board Meeting held on Wednesday November 11 2026 i.e today to consider and approve unaudited financial results for the quarter and half year ended September 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Clarification sought from Pharmaids Pharmaceuticals Ltd

20-Nov-2026 | Source : BSE

The Exchange has sought clarification from Pharmaids Pharmaceuticals Ltd on November 20 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2026 | Source : BSE

Newspaper publication of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2026

Board Meeting Outcome for Outcome Of The Board Meeting

11-Nov-2026 | Source : BSE

outcome of the Board Meeting held on Wednesday November 11 2026 i.e today to consider and approve unaudited financial results for the quarter and half year ended September 30 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available